Immunocore Holdings plc - Ordinary shares (IMCR)

Historical Holders from Q1 2021 to Q3 2025

Symbol: IMCR on Nasdaq
Type / Class: Equity / Ordinary shares
Shares outstanding: 49,942,911
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 49,180,519
Holdings value: $1,786,666,273
% of all portfolios: 0.003%
Number of holders: 131
Number of buys: 58
Number of sells: -64
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Immunocore Holdings plc - Ordinary shares (IMCR)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
T. Rowe Price Investment Management, Inc.	14.1%		$212,682,831		7,051,818		T. Rowe Price Investment Management, Inc.	31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP	10.2%	+12.2%	$177,495,613	+$21,348,793	5,132,898	+13.7%	Wellington Management Group LLP	31 Jul 2025
Jallal Bahija	8.2%		$135,513,072		4,493,139		Jallal Bahija	31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/	7.51%	+43.6%	$130,443,852	+$38,165,393	3,772,234	+41.4%	PRIMECAP MANAGEMENT CO/CA/	30 Jun 2025
Bellevue Group AG	5.6%		$101,607,853		2,796,803		Bellevue Group AG	20 Aug 2025
TANG CAPITAL MANAGEMENT LLC	5.2%		$94,662,520		2,605,608		TANG CAPITAL MANAGEMENT, LLC	17 Oct 2025

Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	49,180,519	$1,786,666,273	+$50,908,665	$62,941,724	$11,654,664	$36.33	131
2025 Q2	47,759,431	$1,498,675,257	+$17,984,702	$36,620,460	$9,194,340	$31.38	132
2025 Q1	47,287,653	$1,402,998,400	+$60,274,148	$3,471,390	$6,367,182	$29.67	115
2024 Q4	45,410,647	$1,339,563,608	-$4,915,367	$1,141,650	$1,711,000	$29.5	114
2024 Q3	45,295,985	$1,411,075,539	+$61,107,953	$14,036,517	$5,989,412	$31.13	129
2024 Q2	43,068,701	$1,459,854,294	-$99,787,937	$3,541,505	$5,158,058	$33.89	135
2024 Q1	41,233,666	$2,679,814,816	+$238,809,048	$6,324,500	$34,794,500	$65	149
2023 Q4	37,514,062	$2,563,043,022	+$32,940,976	$5,226,480	$17,837,936	$68.32	133
2023 Q3	36,945,020	$1,917,423,501	+$85,494,203	$150,510	$10,976,850	$51.9	125
2023 Q2	35,306,138	$2,115,733,529	+$164,020,008	$3,297,800	$18,614,584	$59.96	118
2023 Q1	32,689,414	$1,614,615,481	+$118,700,415	$2,793,360	$16,503,472	$49.44	108
2022 Q4	30,264,419	$1,727,211,273	+$217,928,825	$4,257,422	$9,593,407	$57.07	103
2022 Q3	26,369,515	$1,237,624,033	+$261,557,875	$6,811,000	$1,343,000	$46.94	83
2022 Q2	21,039,614	$784,510,369	+$56,584,747	$4,708,000	$2,786,000	$37.31	66
2022 Q1	19,740,280	$590,138,252	+$57,754,634		$969,000	$29.9	57
2021 Q4	17,133,052	$586,618,000	+$22,048,655			$34.24	45
2021 Q3	16,654,128	$617,381,000	+$83,084,443			$37.07	46
2021 Q2	13,805,464	$538,109,000	+$10,183,214			$39.05	41
2021 Q1	14,110,965	$597,836,000	+$597,835,003			$42.57	41